Newer developments in adult T-cell leukemia/lymphoma therapeutics

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 11, 2011, Pages 1709-1717

  Dasanu, Constantin A ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b LLP   (United States)

Author keywords

Adult T cell leukemia lymphoma (ATL); Antiviral therapy; Human T cell leukemia virus type 1 (HTLV 1); Immunodeficiency; Intensive chemotherapy

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PREDNISONE; RANIMUSTINE; VINCRISTINE; VINDESINE; ZIDOVUDINE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; BONE LESION; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERCALCEMIA; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LEUKEMIA CELL; LEUKEMIA REMISSION; LUNG LESION; LYMPHADENOPATHY; LYMPHOCYTOSIS; MULTICENTER STUDY (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; SKIN MANIFESTATION; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; VIROGENESIS; VIRUS LOAD; VIRUS REPLICATION;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; REMISSION INDUCTION; STEM CELL TRANSPLANTATION;

EID: 79960216545     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.571207     Document Type: Review

References (49)

1. Karube K, Ohshima K, Tsuchiya T, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/ lymphoma cells. Br J Haematol 2004;126:81-4 (Pubitemid 38859486)
2. Karube K, Aoki R, Sugita Y, et al. The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma. Mod Pathol 2008;21:617-25 (Pubitemid 351589656)
3. Chlichlia K, Khazaie K. HTLV-1 Tax: linking transformation, DNA damage and apoptotic T-cell death. Chem Biol Interact 2010;188(2):359-65
4. Giam CZ, Jeang KT. HTLV-1 Tax and adult T-cell leukemia. Front Biosci 2007;12:1496-507
5. Boxus M, Willems L. Mechanisms of HTLV-1 persistence and transformation. Br J Cancer 2009;101(9):1497-501.
6. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79(3):428-37
7. Matutes E. Adult T-cell leukaemia/ lymphoma. J Clin Pathol 2007;60(12):1373-7. (Pubitemid 350247253)
8. Kannagi M. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia. Int J Hematol 2007;86(2):113-17 (Pubitemid 47425187)
9. Fritsch-Stork RD, Leguit RJ, Derksen RH. Rapidly fatal HTLV-1-associated T-cell leukemia/ lymphoma in a patient with SLE. Nat Rev Rheumatol 2009;5(5):283-7
10. Shimamoto Y, Nomura S, Ishii K, et al. Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus. Int J Hematol 2009;89(1):128-9
11. Pawson R, Richardson DS, Pagliuca A, et al. Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases. Leuk Lymphoma 1998;31(1-2):177-85 (Pubitemid 28428761)
12. Okayama A. Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection. Rinsho Byori 2005;53(9):837-44
13. Moriyama K, Muranishi H, Nishimura J, et al. Immunodeficiency in preclinical smoldering adult T-cell leukemia. Jpn J Clin Oncol 1988;18(4):363-9
14. Kimura A, Ueyama H, Kimura N, et al. Progressive multifocal leukoencephalopathy in an HTLV-I carrier. Clin Neurol Neurosurg 2006;108(8):768-71 (Pubitemid 44709775)
15. Bazarbachi A, Ghez D, Lepelletier Y, et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004;5:664-72 (Pubitemid 40267851)
16. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005;24:6047-57 (Pubitemid 43086122)
17. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma. Br J Haematol 2001;113:375-82 . A study from Japan showing an encouraging response of patients with ATL lymphoma-type to chemotherapy. (Pubitemid 32523141)
18. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007;25(34):5458-64. (Pubitemid 350232223)
19. Bazarbachi A, Plumelle Y, Carlos Ramos J, et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 2010;28(27):4177-83.
20. Hermine O, Bouscary D, Guessain A, et al. Brief report: treatment of HTLV-1 associated adult T-cell leukemia-lymphoma with a combination of zidovudine and alphainterferon. N Engl J Med 1995;332:1749-51 . An early study showing a high response rate of ATL to zidovudine combined with IFN-a.
21. Gill PS, Harrington W Jr, Kaplan MH, et al. Treatment of adult T-cell leukemialymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995;332:1744-8.
22. Matutes E, Taylor GP, Cavenagh J, et al. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol 2001;113:779-84 (Pubitemid 32524403)
23. Hermine O, Allard I, Levy V, et al. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult Tcell leukemia/lymphoma. Haematology J 2002;3:276-82 (Pubitemid 36163756)
24. Datta A, Bellon M, Sinha-Datta U, et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 2006;108:1021-9 (Pubitemid 44154640)
25. Mahieux R. HTLV-I and AZT: die another day. Blood 2006;108:785-6 (Pubitemid 44154605)
26. Bazarbachi A, Hermine O. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/ lymphoma patients. J AIDS 1996;13(Suppl 1):S186-90
27. Ramos JC, Ruiz P Jr, Ratner L, et al. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/ lymphoma. Blood 2007;109:3060-8 (Pubitemid 46482107)
28. Hill SA, Lloyd PA, McDonald S, et al. Susceptibility of human T cell leukemia virus type 1 to nucleoside reverse transcriptase inhibitors. J Infect Dis 2003;188:424-7 (Pubitemid 36960653)
29. Taylor GP, Goon P, Furukawa Y, et al. Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology 2006;3:63
30. Dewan MZ, Uchihara JN, Terashima K, et al. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. Blood 2006;107(2):716-24 (Pubitemid 43076398)
31. Takasaki Y, Iwanaga M, Imaizumi Y, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010;115(22):4337-43
32. Shimoyama M. Treatment of patients with adult T-cell leukemia-lymphoma: an overview. In: Takatsuki K, Hinuma Y, Yoshida M, editors, Advances in Adult T-Cell Leukemia and HTLV-I Research. Japan Scientific Societies, Tokyo, Japan; p. 43-56
33. Alduaij A, Butera JN, Treaba D, et al. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature. Clin Lymphoma Myeloma Leuk 2010;10(6):480-3.
34. Phillips AA, Willim RD, Savage DG, et al. A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients. Leuk Lymphoma 2009;50(6):1039-42
35. Utsunomiya A, Miyakazi Y, Takatsuka Y, et al. Improved outcome of adult T-cell leukemia/lymphoma by allogeneic stem cell transplantation. Bone Marrow Transplant 2001;27:15-20 (Pubitemid 32124402)
36. Kami M, Hamaki T, Miyakoshi S, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003;120:304-9 (Pubitemid 36194182)
37. Nakase K, Hara M, Kozuka T, et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant 2006;37:41-4 (Pubitemid 43135313)
38. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010;116(8):1369-76.
39. Okamura J, Uike N, Utsunomiya A, et al. Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma. Int J Hematol 2007;86(2):118-25 (Pubitemid 47425188)
40. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hematop 2010;50(1):9-25.
41. Evens AM, Ziegler SL, Gupta R, et al. Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/ lymphoma. Clin Lymphoma Myeloma 2007;7(7):472-4 (Pubitemid 47436648)
42. Mone A, Puhalla S, Whitman S, et al. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/ IFN-{alpha}-refractory adult T-cell leukemia. Blood 2005;106(10):3380-2 (Pubitemid 41609170)
43. Marneros AG, Grossman ME, Silvers DN, et al. Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions. Blood 2009;113(25):6338-41
44. Yamamoto K, Utsunomiya A, Tobinai K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 2010;28(9):1591-8
45. Tanosaki R, Tobinai K. Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches. Expert Rev Hematol 2010;3(6):743-53
46. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79(3):428-37
47. Yamaguchi K, Matutes E, Catovsky D, et al. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet 1987;2:94-5
48. Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000;19:4954-60
49. Satoh M, Toma H, Sugahara K, et al. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(-)25(-) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene 2002;21:2466-75